(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIORTUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BIORTUS

ST13

US500000086723314

Class

5, 42

Filing

86723314

Registration

5039200

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

07/23/2026

Trademark type

Combined

Nice classes

5, 42

Filing date

08/12/2015

Registration date

09/13/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/18/2026

Last transaction

07/23/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

05/16/2013

First use in commerce

05/16/2013

Drawing code

3

Owner type

99

Owner location

JIANGSU PROVINCE, CN

Examiner

VIGIL, JACOB EUGENE

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of stylized wording "BIORTUS" with letters "BI" in blue and letters "ORTUS" in green with a solid green circle in place of the "O" . There is a blue semicircle at the right side of the circle.

Holders and representatives

Holders

BIORTUS BIOSCIENCES CO., LTD.
Wuxi Biortus Biosciences Co., Ltd.

Representatives

Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-cancer preparations; Antibacterial pharmaceuticals; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposesfor cancerdiabeteshypertensionbone diseasesasthma and allergies; Chemical preparations for sanitary purposes; Enzymes for veterinary purposes; Ferments for pharmaceutical purposes; Opium alkaloid preparations; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; for the treatment of inflammatory disorders; for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for use in chemotherapy; Reagents for medical use; Vaccines

Class 42

Biological research; Chemistry consultation; Material testing; Packaging design; Physics research; Product quality testing; Research and development of new products

Publications

History of USPTO decisions and trademark events.

45 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/22/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/22/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/22/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/22/2026

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/18/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/18/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/18/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/18/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

11/18/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/13/2025

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

06/11/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/16/2024

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

05/07/2024

ES7R

TEAS SECTION 7 REQUEST RECEIVED

05/07/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/06/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/06/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/06/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/06/2024

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

04/17/2023

8.PR

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED

04/17/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/17/2023

ES8R

TEAS SECTION 8 RECEIVED

09/12/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/13/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

09/13/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/28/2016

PUBO

PUBLISHED FOR OPPOSITION

06/28/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/08/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/25/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/25/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/23/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/23/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/23/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/16/2016

GNRT

NON-FINAL ACTION E-MAILED

02/16/2016

CNRT

NON-FINAL ACTION WRITTEN

02/16/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/29/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/29/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/29/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/25/2015

GNRT

NON-FINAL ACTION E-MAILED

11/25/2015

CNRT

NON-FINAL ACTION WRITTEN

11/25/2015

DOCK

ASSIGNED TO EXAMINER

11/24/2015

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/19/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/18/2015

NWAP

NEW APPLICATION ENTERED

08/17/2015

Continuous trademark protection

Get notified about every new filing that threatens BIORTUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.